C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer's Trust to Improve Alzheimer's Disease Diagnosis

LONDON--(BUSINESS WIRE)-- #Alzheimers--C2N Diagnostics, LLC ("C2N"), a pioneer in advanced diagnostic testing for brain health, and Cambridge Cognition, the neuroscience technology company, announce on World Alzheimer’s Day a partnership with The Alzheimer's Trust, a newly formed subsidiary of The Cancer Screening Trust, to address the urgent and growing burden of Alzheimer's disease and related dementias in the United Kingdom (UK).The collaboration creates an integrated, scalable pathway for ea